| dc.description.abstract | Background: Antenatal corticosteroid administration is used to prevent
respiratory complications in premature neonates has been linked with increased
risk of hypoglycemia. The incidence of hypoglycemia in high-risk neonates is
30%.The aim of this study is to analyze the association between risk of
hypoglycemia in premature neonates and antenatal corticosteroid administration.
Method: This is an analytic research with cohort design conducted in Adam
Malik Hospital from December 2023 to February 2024. Blood glucose assessment
is carried out using blood glucose monitoring device within 1 and 4 hours after
birth. Statistical analysis is carried out using Fischer’s Exact, Mann Whitney and
independent T-tests to find the relationship between hypoglycemia and antenatal
dexamethasone administration.
Result: A total of 30 neonates met the criteria in this study. There were
13(43,3%) neonates with incomplete doses of dexamethasone, while 17(56,7%)
had complete doses. Mild hypoglycemia occurred in 1(7,7%) and 2(11,8%)
neonates with incomplete and complete doses of dexamethasone. The 1-hour after
birth blood glucose level in neonates with incomplete and complete dose of
dexamethasone were 85±30,67 mg/dL and 75±15,85 mg/dL,the 4-hour blood
glucose level was 90,39±10,53 mg/dL and 91,59±12,82 mg/dL. The analysis
showed that there is no relationship between hypoglycemia and dexamethasone
administration.
Conclusion: There is no association between risk of hypoglycemia in premature
neonates with antenatal dexamethasone administration. | en_US |
